AmbioPharm is one of the world’s largest custom peptide manufacturers. We can synthesize nearly any type of custom peptide with any modification(s) that you need at any desired scale.
AmbioPharm has multiple manufacturing suites capable of producing research and GMP peptides and APIs (Active Pharmaceutical Ingredients) at varying scales from gram to multi-kilogram scale. Depending upon the project, we use solid phase peptide synthesis (SPPS), solution phase peptide synthesis (liquid phase peptide synthesis), and hybrid solid/solution phase synthesis methods to produce peptide APIs.
Cutting-edge technology, stringent quality controls, and innovative management strategies allow AmbioPharm to produce high-quality custom peptides for the world’s leading pharmaceutical, biotech, university and clinical research labs, whether you need research, preclinical, or cGMP peptides.
We pride ourselves on producing consistently high-quality products for each and all of our clients’ needs.
Our custom peptides can be reviewed and released by our in-house Quality Control Unit in as little as 3-4 weeks.
At our current facilities, AmbioPharm has the capacity to handle any custom peptide synthesis project at scale. The new commercial building completed in 2017 in Shanghai added 6 additional manufacturing lines to increase overall capacity. New building constructions are also currently under way in Shanghai and North Augusta which will more than triple our current capacity.
Purification scales range from 1g to 30 kg/batch final peptide.